Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). PT Bundamedik Tbk's share price for the quarter that ended in Mar. 2026 was Rp190. PT Bundamedik Tbk's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 8,603 Mil. Therefore, PT Bundamedik Tbk's market cap for the quarter that ended in Mar. 2026 was Rp1,634,649 Mil.
PT Bundamedik Tbk's quarterly market cap
increased
from Sep. 2025 (Rp1,445,374 Mil) to Dec. 2025 (Rp1,634,649 Mil) but then
stayed the same
from Dec. 2025 (Rp1,634,649 Mil) to Mar. 2026 (Rp1,634,649 Mil).
PT Bundamedik Tbk's annual market cap
declined
from Dec. 2023 (Rp2,804,714 Mil) to Dec. 2024 (Rp2,116,440 Mil) and
declined
from Dec. 2024 (Rp2,116,440 Mil) to Dec. 2025 (Rp1,634,649 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. PT Bundamedik Tbk's Enterprise Value for Today is Rp3,038,464 Mil.
PT Bundamedik Tbk (ISX:BMHS) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
PT Bundamedik Tbk Market Cap Related Terms
PT Bundamedik Tbk Market Cap Historical Data
* Premium members only.
The historical data trend for PT Bundamedik Tbk's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, PT Bundamedik Tbk's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Bundamedik Tbk Market Cap vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PT Bundamedik Tbk's Market Cap distribution charts can be found below:
* The bar in red indicates where PT Bundamedik Tbk's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
PT Bundamedik Tbk's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Bundamedik Tbk (ISX:BMHS) has a Market Cap of Rp1,471,184 Mil as of Jul. 04, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on PT Bundamedik Tbk and its competitors. According to the industry distribution chart, PT Bundamedik Tbk ranks #368 out of 695 companies in the Healthcare Providers & Services industry, placing it in the top 52.9%.
Is PT Bundamedik Tbk's Market Cap too high?
PT Bundamedik Tbk's current Market Cap is Rp1,471,184 Mil. Based on the distribution chart, PT Bundamedik Tbk ranks #368 out of 695 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, PT Bundamedik Tbk has a GF Score™ of 60/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does PT Bundamedik Tbk's Market Cap compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, PT Bundamedik Tbk ranks #368 out of 695 companies for Market Cap. This places PT Bundamedik Tbk in the lower half of its industry. The industry median Market Cap is 97.60. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Healthcare Providers & Services company?
The median Market Cap among Healthcare Providers & Services companies is 97.60, based on 695 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on PT Bundamedik Tbk and its competitors. For the Healthcare Providers & Services industry, the median Market Cap is 97.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Bundamedik Tbk's current Market Cap is Rp1,471,184 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Bundamedik Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Bundamedik Tbk (ISX:BMHS) is currently considered Possible Value Trap. The stock's GF Value™ is Rp305.66, compared to a current price of Rp171.00 — trading 44.1% below its estimated fair value. The current Market Cap is Rp1,471,184 Mil. PT Bundamedik Tbk's overall GF Score™ is 60/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For PT Bundamedik Tbk (ISX:BMHS), the current Market Cap is Rp1,471,184 Mil as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Bundamedik Tbk (ISX:BMHS) Overvalued in 2026?
Based on GuruFocus' analysis, PT Bundamedik Tbk stock appears to be undervalued.
The current stock price of Rp171.00 is trading 44.1% below its estimated GF Value™ of Rp305.66.
GuruFocus considers PT Bundamedik Tbk to be Possible Value Trap.
Key valuation signals for ISX:BMHS:
Market Cap: Rp1,471,184 Mil
GF Value™: Rp305.66 vs. price of Rp171.00 (44.1% below fair value)
No single metric tells the full story. See the ISX:BMHS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Bundamedik Tbk is a healthcare service provider. The Company carries out its main business activities through private hospital activities. It offers maternal and child health services, outpatient services, inpatient services, emergency services, service excellence centers, IVF services, and Clinical laboratory services.
60GF Score
Get the complete analysis for ISX:BMHS
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:BMHS has been successfully added to your 
